In a study on 177 cases of well-differentiated breast cancers that were HER2-borderline on IHC, the rate of HER2 amplification by FISH was 1.7% (3/177) and all three HER2-positive tumors had low levels of amplification (30). The gene discussed is ERBB2; the disease is breast cancer.